Search

Sun Jae Yoo

Examiner (ID: 4021, Phone: (571)272-9074 , Office: P/1626 )

Most Active Art Unit
1626
Art Unit(s)
1622, 1609, 1626, 1621
Total Applications
1924
Issued Applications
1172
Pending Applications
219
Abandoned Applications
564

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19274398 [patent_doc_number] => 12024509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => Therapeutic compounds as inhibitors of the orexin-1 receptor [patent_app_type] => utility [patent_app_number] => 16/814328 [patent_app_country] => US [patent_app_date] => 2020-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52001 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 865 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16814328 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/814328
Therapeutic compounds as inhibitors of the orexin-1 receptor Mar 9, 2020 Issued
Array ( [id] => 16120169 [patent_doc_number] => 20200212107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-02 [patent_title] => PHOTOELECTRIC CONVERSION ELEMENT, OPTICAL SENSOR, AND IMAGING ELEMENT [patent_app_type] => utility [patent_app_number] => 16/812378 [patent_app_country] => US [patent_app_date] => 2020-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13041 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16812378 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/812378
Photoelectric conversion element, optical sensor, and imaging element Mar 8, 2020 Issued
Array ( [id] => 17609672 [patent_doc_number] => 20220151951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => Preparation for topical use for dermatological treatments [patent_app_type] => utility [patent_app_number] => 17/436636 [patent_app_country] => US [patent_app_date] => 2020-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3532 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436636 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/436636
Preparation for topical use for dermatological treatments Mar 8, 2020 Abandoned
Array ( [id] => 16312315 [patent_doc_number] => 20200291053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-17 [patent_title] => METAL COMPLEX AS SENSOR COMPOUND FOR DETECTING GAS ANALYTE [patent_app_type] => utility [patent_app_number] => 16/811678 [patent_app_country] => US [patent_app_date] => 2020-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1441 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811678 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/811678
Metal complex as sensor compound for detecting gas analyte Mar 5, 2020 Issued
Array ( [id] => 17672648 [patent_doc_number] => 20220185815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => PYRROLOPYRAZOLE DERIVATIVE [patent_app_type] => utility [patent_app_number] => 17/436500 [patent_app_country] => US [patent_app_date] => 2020-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59108 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436500 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/436500
Pyrrolopyrazole derivative Mar 4, 2020 Issued
Array ( [id] => 17625678 [patent_doc_number] => 20220160693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => PHARMACEUTICAL COMPOSITION OF PROLYL HYDROXYLASE INHIBITOR AND PREPARATION METHOD THEREFOR [patent_app_type] => utility [patent_app_number] => 17/434831 [patent_app_country] => US [patent_app_date] => 2020-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434831 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/434831
PHARMACEUTICAL COMPOSITION OF PROLYL HYDROXYLASE INHIBITOR AND PREPARATION METHOD THEREFOR Mar 2, 2020 Abandoned
Array ( [id] => 19674563 [patent_doc_number] => 12186401 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-07 [patent_title] => Amide-based proteolysis modulators of B-rapidly accelerated fibrosarcoma (BRAF) and associated uses [patent_app_type] => utility [patent_app_number] => 17/310837 [patent_app_country] => US [patent_app_date] => 2020-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15562 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310837 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/310837
Amide-based proteolysis modulators of B-rapidly accelerated fibrosarcoma (BRAF) and associated uses Mar 1, 2020 Issued
Array ( [id] => 17576802 [patent_doc_number] => 20220133657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => COMPOUNDS FOR PREVENTION AND TREATMENT OF OBESITY AND RELATED DISORDERS [patent_app_type] => utility [patent_app_number] => 17/435678 [patent_app_country] => US [patent_app_date] => 2020-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14613 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435678 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/435678
Compounds for prevention and treatment of obesity and related disorders Mar 1, 2020 Issued
Array ( [id] => 18280556 [patent_doc_number] => 20230096028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => BICYCLIC HETEROCYCLYL COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/310932 [patent_app_country] => US [patent_app_date] => 2020-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86165 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 404 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310932 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/310932
BICYCLIC HETEROCYCLYL COMPOUNDS AND USES THEREOF Mar 1, 2020 Abandoned
Array ( [id] => 17627160 [patent_doc_number] => 20220162175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => METHOD FOR PRODUCING N-(HYDROCARBON)ISOCYANURIC ACID [patent_app_type] => utility [patent_app_number] => 17/434803 [patent_app_country] => US [patent_app_date] => 2020-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11945 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434803 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/434803
Method for producing N-(hydrocarbon)isocyanuric acid Mar 1, 2020 Issued
Array ( [id] => 17759866 [patent_doc_number] => 20220233478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING HYDROXYUREA FOR USE IN THE TREATMENT OF SEVERE CHRONIC ANEMIA [patent_app_type] => utility [patent_app_number] => 17/433869 [patent_app_country] => US [patent_app_date] => 2020-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4129 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433869 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/433869
PHARMACEUTICAL COMPOSITION CONTAINING HYDROXYUREA FOR USE IN THE TREATMENT OF SEVERE CHRONIC ANEMIA Feb 27, 2020 Abandoned
Array ( [id] => 17561652 [patent_doc_number] => 20220125801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => OPHTHALMIC COMPOSITION OF BIMATOPROST [patent_app_type] => utility [patent_app_number] => 17/435095 [patent_app_country] => US [patent_app_date] => 2020-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4561 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435095 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/435095
OPHTHALMIC COMPOSITION OF BIMATOPROST Feb 26, 2020 Abandoned
Array ( [id] => 20633403 [patent_doc_number] => 12594266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-04-07 [patent_title] => Triterpenoid antifungals for the treatment or prevention of [patent_app_type] => utility [patent_app_number] => 17/432926 [patent_app_country] => US [patent_app_date] => 2020-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6648 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432926 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/432926
Triterpenoid antifungals for the treatment or prevention of Feb 24, 2020 Issued
Array ( [id] => 17362615 [patent_doc_number] => 11229623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-25 [patent_title] => TRPV4 antagonists [patent_app_type] => utility [patent_app_number] => 16/796989 [patent_app_country] => US [patent_app_date] => 2020-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48279 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 404 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16796989 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/796989
TRPV4 antagonists Feb 20, 2020 Issued
Array ( [id] => 17680967 [patent_doc_number] => 11365206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-21 [patent_title] => BCL-2 inhibitors [patent_app_type] => utility [patent_app_number] => 16/795720 [patent_app_country] => US [patent_app_date] => 2020-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25517 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 689 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795720 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/795720
BCL-2 inhibitors Feb 19, 2020 Issued
Array ( [id] => 17546642 [patent_doc_number] => 20220117983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => METHODS FOR TREATING LIVER CANCERS USING AN ORALLY ADMINISTERED DIOXOLANE NUCLEOTIDE IN COMBINATION WITH AN ANTI-PD1 OR ANTI-PDL1 MONOCLONAL ANTIBODY [patent_app_type] => utility [patent_app_number] => 17/431686 [patent_app_country] => US [patent_app_date] => 2020-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15576 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431686 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/431686
Methods for treating liver cancers using an orally administered dioxolane nucleotide in combination with an anti-PD1 or anti-PDL1 monoclonal antibody Feb 16, 2020 Issued
Array ( [id] => 17473938 [patent_doc_number] => 20220081442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-17 [patent_title] => 3,6-DISUBSTITUTED-2-PYRIDINALDOXIME SCAFFOLDS [patent_app_type] => utility [patent_app_number] => 17/430876 [patent_app_country] => US [patent_app_date] => 2020-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17741 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430876 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/430876
3,6-disubstituted-2-pyridinaldoxime scaffolds Feb 13, 2020 Issued
Array ( [id] => 20115996 [patent_doc_number] => 12365685 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-22 [patent_title] => Substituted fused aromatic ring derivative, composition and use thereof [patent_app_type] => utility [patent_app_number] => 17/426373 [patent_app_country] => US [patent_app_date] => 2020-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15913 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426373 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/426373
Substituted fused aromatic ring derivative, composition and use thereof Feb 12, 2020 Issued
Array ( [id] => 19701788 [patent_doc_number] => 12195804 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-14 [patent_title] => Treatment of squamous cell carcinoma [patent_app_type] => utility [patent_app_number] => 16/790471 [patent_app_country] => US [patent_app_date] => 2020-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 69 [patent_no_of_words] => 24628 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790471 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/790471
Treatment of squamous cell carcinoma Feb 12, 2020 Issued
Array ( [id] => 17655256 [patent_doc_number] => 20220175721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => TREATMENT FOR POLYCYSTIC OVARIAN SYNDROME (PCOS) [patent_app_type] => utility [patent_app_number] => 17/430381 [patent_app_country] => US [patent_app_date] => 2020-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11170 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430381 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/430381
TREATMENT FOR POLYCYSTIC OVARIAN SYNDROME (PCOS) Feb 11, 2020 Abandoned
Menu